Nephrology
From the Journals
Low RAAS inhibitor dosing linked to MACE risk
Reducing the dose of renin-angiotensin-aldosterone system inhibitors to manage hyperkalemia could increase the risk of cardiovascular events.
Conference Coverage
ISCHEMIA-CKD: No benefit for coronary revascularization in advanced CKD with stable angina
PHILADELPHIA – At 3 years, more than 27% of patients were dead regardless of the coronary artery disease management strategy.
Conference Coverage
Novel antibody looks promising in lupus nephritis
WASHINGTON – “We hypothesized that if we could deplete B cells more efficiently and completely, we would achieve better results.”
Article
FDA approves cefiderocol for multidrug-resistant, complicated urinary tract infections
The approval is for patients with limited or no alternative treatment options and includes a warning of Fetroja’s higher all-cause mortality rate...
Conference Coverage
New model for CKD risk draws on clinical, demographic factors
The equation has demonstrated high discrimination and variable calibration across a range of populations.
Conference Coverage
Patiromer allows more CKD patients to continue on spironolactone
PHILADELPHIA – After 12 weeks, 86% of the patiromer patients remained on spironolactone, vs. 66% of the placebo patients.
From the Journals
HCV+ kidney transplants: Similar outcomes to HCV- regardless of recipient serostatus
Conference Coverage
F-BEVAR safe in patients with one kidney
CHICAGO – Patients with a single functioning kidney and those with two had similar outcomes after fenestrated-branched endovascular repair of AAAs...
News
FDA adds diabetic kidney disease, heart failure indications to canagliflozin
This marks the first time in 20 years that a drug has been indicated for diabetic kidney disease treatment, according to the manufacturer.
From the Journals
USPSTF: Screening pregnant women for asymptomatic bacteriuria cuts pyelonephritis risk
But the new recommendations urge clinicians to refrain from testing asymptomatic nonpregnant women and adult men.
From the Journals
Type of renal dysfunction affects liver cirrhosis mortality risk
Patients with acute on chronic kidney disease fared the worst.